Work

Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes.

Year: 2016

Type: article

Abstract: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment option in selected patients with peritoneal dissemination from a variety of epithelial primaries. Even though a small proportion will be alive and potentially cured at 10 years, the majority will eventually develop recurrent disease. Repeat CRS/HIPEC is a valid consideration in a selected subpopulation of patients with isolated peritoneal recurrence. This review summarizes the data on patient selection, feasibility, limitations and outcomes of repeat CRS/HIPEC.

Source: Europe PMC (PubMed Central)

DOI: 10.3978/j.issn.2078-6891.2015.131

Authors: Harveshp Mogal, Konstantinos Chouliaras, Edward A Levine, Perry Shen, Konstantinos I Votanopoulos

Institution: Wake Forest University

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2195652722

FWCI: 3.693

Cites: 95

Cited by: 32

Related to: 10